Journal List > Prog Med Phys > v.30(1) > 1120036

Kang, Chung, Kim, Kang, Eom, Song, Kim, and Kim: Comparison of Dosimetrical and Radiobiological Parameters on Three VMAT Techniques for Left-Sided Breast Cancer

Abstract

Purpose:

To compare the dosimetrical and radiobiological parameters among various volumetric modulated arc therapy (VMAT) techniques using restricted and continuous arc beams for left-sided breast cancer.

Materials and Methods:

Ten patients with left-sided breast cancer without regional nodes were retrospectively selected and prescribed the dose of 42.6 Gy in 16 fractions on the planning target volume (PTV). For each patient, three plans were generated using the EclipseTM system (Varian Medical System, Palo Alto, CA) with one partial arc 1pVMAT, two partial arcs 2pVMAT, and two tangential arcs 2tVMAT. All plans were calculated through anisotropic analytic algorithm and photon optimizer with 6 MV photon beam of VitalBEAMTM. The same dose objectives for each plan were used to achieve a fair comparison during optimization.

Results:

For PTV, dosimetrical parameters such as Homogeneity index, conformity index, and conformal number were superior in 2pVMAT than those in both techniques. V95%, which indicates PTV coverage, was 91.86%, 96.60%, and 96.65% for 1pVMAT, 2pVMAT, and 2tVMAT, respectively. In most organs at risk (OARs), 2pVMAT significantly reduced the delivered doses compared with the other techniques, excluding the doses to contralateral lung. For the analysis of radiobiological parameters, a significant difference in normal tissue complication probability was observed in ipsilateral lung while no difference was observed in the other OARs.

Conclusions:

Our study showed that 2pVMAT had better plan quality and normal tissue sparing than 1pVMAT and 2tVMAT but not for all parameters. Therefore, 2pVMAT could be considered the priority choice for the treatment planning for left breast cancer.

REFERENCES

1.Fisher B., Anderson S., Bryant J, et al. Twenty-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002. 347(16):1233–1241.
crossref
2.Veronesi U., Cascinelli N., Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002. 347(16):1227–1232.
crossref
3.Munshi A., Pai RH., Phurailatpam R, et al. Do all patients of breast carcinoma need 3-dimensional CT-based planning? A dosimetric study comparing different breast sizes. Med Dosim. 2009. 34(2):140–144.
crossref
4.Pignol J., Olivotto I., Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008. 26(13):2085–2092.
crossref
5.Bird B., Swain S. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems. Clin Cancer Res. 2008. 14(1):14–24.
crossref
6.Lohr F., El-Haddad M., Dobler B, et al. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys. 2009. 74(1):73–80.
crossref
7.Schubert LK, et al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and topotherapy. Radiother Oncol. 2010. 100(2):241–246.
crossref
8.Nilsson G., Holmberg L., Garmo H., Duvernoy O., Sjögren I., Lagerqvist B, et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012. 30(4):380–386.
crossref
9.Darby SC., Ewertz M., McGale P., Bennet AM., Blom-Goldman U., Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013. 368(11):987–998.
crossref
10.Hurkmans CW., Cho BCJ., Damen E., Zijp L., Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol. 2002. 62(2):163–171.
crossref
11.Hong L., Hunt M., Chui C., Spirou S., Forster K., Lee H, et al. Intensity modulated tangential beam irradiation of the intact breast. Int J Radiat Oncol Biol Phys. 1999. 44(5):1155–1164.
12.Xu XL., Wu H., Han SK. Dosimetry study of intensity modulated radiation therapy for left side breast cancer. Chinese Journal of Radiation Oncology. 2006. 15(3):192–195.
13.Virén Tuomas, et al. Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy. Radiol Oncol. 2015. 10(1):79.
crossref
14.Jin Guang-Hua, et al. A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT. Radiol Oncol. 2013. 8(1):89.
crossref
15.Qiu Jian-Jian, et al. Dosimetric comparison of 3D conformal, IMRT, and V-MAT techniques for accelerated partial-breast irradiation (APBI). Med Dosim. 2014. 39(2):152–158.
crossref
16.Badakhshi H., Kaul D., Nadobny J., Wille B., Sehouli J., Budach V. Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol. 2013. 86(1032):20130515.
crossref
17.Munshi Anusheel, et al. Short tangential arcs in VMAT based breast and chest wall radiotherapy lead to conformity of the breast dose with lesser cardiac and lung doses: a prospective study of breast conservation and mastectomy patients. Australas Phys Eng Sci Med. 2017. 40(3):729–736.
crossref
18.Fogliata Antonella, et al. Dosimetric trade-offs in breast treatment with VMAT technique. Br J Radiol. 2016. 90(1070):20160701.
crossref
19.Whelan. Timothy J, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010. 362(6):513–520.
20.Gay HA., Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med. 2007. 23:115–125.
crossref
21.Liu Haiyun, et al. Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study. Comput Med Imaging Graph. 2016. 54:1–5.
crossref
22.Vicini F.., Freedman G. M.., White J. R.A phase III trial of accelerated whole breast irradiation with hypofraction-ation plus concurrent boost versus standard whole breast irradiation plus sequential boost for early-stage breast cancer. RTOG 1005. 2012.
23.Xi Dan, et al. Advantages of a technique using two 50 degree arcs in simultaneous integrated boost radiotherapy for left-sidebreast cancer. Sci Rep. 2017. 7(1):14748.
crossref

Fig. 1
Example of dose distribution in transverse plane for (a) 1pVMAT, (b) 2pVMAT, and (c) 2tVMAT.
pmp-30-7f1.tif
Table 1.
The optimization objectives used for inverse IMRT VMAT planning.
Structure Objectives
PTV V44.6Gy<1%, V42.5Gy>95%, V40.4Gy>100%
Heart V10Gy<20% and V20Gy<10%, Dmean<5 Gy
Left lung V10Gy<40%, V20Gy<30% and V30Gy<20%
Contralateral lung V10Gy<10%
Table 2.
Dosimetrical parameters to PTV obtained by three VMAT techniques (mean±standard deviation).
Metric 1pVMAT 2pVMAT 2tVMAT P-value
1pVMAT vs. 2pVMAT 2pVMAT vs. 2tVMAT
Dmax (%) 118.38±1.72 114.93±1.83 115.10±2.25 0.009 0.553
Dmean (%) 102.51±1.86 103.06±1.65 102.84±1.70 0.008 0.007
V95% (%) 91.86±3.58 97.60±1.25 96.65±1.86 0.005 0.009
HI 0.21±0.04 0.12±0.02 0.14±0.03 0.005 0.007
CI 1.12±0.13 1.08±0.11 1.12±0.11 0.017 0.004
CN 0.76±0.05 0.88±0.06 0.83±0.05 0.005 0.005
Table 3.
Dosimetrical and statistical analysis for the organs at risk according to three VMAT techniques (mean±standard deviation).
Organ Metric 1pVMAT 2pVMAT 2tVMAT P-value
1pVMAT vs. 2pVMAT 2pVMAT vs. 2tVMAT
Ipsilateral lung Dmax (%) 115.58±3.81 105.88±1.96 109.57±4.08 0.005 0.007
Dmean (%) 32.60±3.21 28.67±1.71 30.27±2.84 0.005 0.011
V20Gy (%) 26.11±3.34 21.43±1.11 22.76±2.33 0.005 0.022
V10Gy (%) 43.13±6.59 37.49±3.76 39.75±4.95 0.005 0.017
NTCP 0.04±0.03 0.01±0.01 0.02±0.01 0.011 0.038
Contralateral lung Dmax (%) 53.02±8.56 62.51±11.39 47.49±10.66 0.114 0.028
Dmean (%) 6.81±1.65 10.29±6.94 6.94±1.13 0.005 0.007
V20Gy (%) 0.04±0.02 0.41±0.48 0.12±0.06 0.080 0.655
V10Gy (%) 1.70±1.29 4.91±3.23 1.38±1.23 0.009 0.022
V5Gy (%) 16.30±8.17 30.48±11.89 13.61±5.48 0.005 0.013
NTCP <0.001 <0.001 <0.001 - -
Heart Dmax (%) 112.23±9.35 89.24±7.43 97.64±9.03 0.005 0.007
Dmean (%) 17.79±4.03 14.66±1.82 15.98±3.83 0.012 0.185
V20Gy (%) 7.95±6.05 3.07±1.12 6.05±2.93 0.005 0.007
V10Gy (%) 19.77±7.02 15.21±4.05 16.60±8.51 0.012 0.445
NTCP <0.001 <0.001 <0.001 - -
TOOLS
Similar articles